S
RDY icon

Steadtrust’s Dr. Reddy's Laboratories RDY Stock Holding History

Steadtrust’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-36,350
Closed -$508K – 130
2025
Q3 		$508K Hold
36,350
– – 0.34% 75
2025
Q2 		$546K Buy
+36,350
New +$519K 0.43% 69

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Steadtrust's RDY Position: Q4 2025 in Review

Steadtrust sold out of Dr. Reddy's Laboratories (RDY) in Q4 2025, closing a stake of 36,350 shares — an estimated $508K sold.

Steadtrust first reported a position in RDY in Q2 2025 and held it in 2 quarters. The position peaked at $546K in Q2 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q4 2025.

  • Steadtrust reported no remaining Dr. Reddy's Laboratories position as of Q4 2025 after selling out during the quarter.
  • Steadtrust sold 36,350 Dr. Reddy's Laboratories shares in Q4 2025, an estimated $508K.
  • Steadtrust first reported a position in Dr. Reddy's Laboratories in Q2 2025 and held it in 2 quarters.
  • Steadtrust's Dr. Reddy's Laboratories position peaked at $546K in Q2 2025.
  • 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2025.

Based on Steadtrust's 13F filing for Q4 2025, filed 21 Jan 2026.